Challenger Limited (CFIGY)
| Market Cap | 5.59B +38.8% |
| Revenue (ttm) | 1.98B -4.9% |
| Net Income | 349.78M +199.1% |
| EPS | 4.77 +186.4% |
| Shares Out | n/a |
| PE Ratio | 14.50 |
| Forward PE | 17.13 |
| Dividend | 2.32 (3.35%) |
| Ex-Dividend Date | Aug 28, 2026 |
| Volume | 252 |
| Open | 69.19 |
| Previous Close | 43.70 |
| Day's Range | 69.19 - 69.19 |
| 52-Week Range | 69.19 - 69.19 |
| Beta | 0.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 10, 2027 |
About Challenger
Challenger Limited is a publicly owned investment manager. The company also provides retirement services to its clients. It manages equity mutual funds. The firm invests into the public equity markets across the world. Challenger Limited was founded in 1985 and is based in Australia, Asia and United Kingdom. [Read more]
Financial Performance
In fiscal year 2026, Challenger's revenue was 2.87 billion, an increase of 0.57% compared to the previous year's 2.85 billion. Earnings were 505.60 million, an increase of 162.92%.
Financial numbers in AUD Financial StatementsNews
Challenger Transcript: AGM 2026
FY 2026 delivered higher normalized earnings, record annuity sales, dividends and buybacks. Growth plans target retirement partnerships, funding and reinsurance, while the board rejected the TAL Daiichi Life offer at AUD 11.80 per share.
Challenger Slides: FY 2026
Challenger has posted slides in relation to its FY 2026 quarterly earnings report, which was published on October 28, 2026.
Challenger Q1 Sales, AUM Climb; To Consider A$11.80/shr Offer From Daiichi Life Unit; Shares Jump
(RTTNews) - Challenger Ltd. (CFIGF.PK, CGF.AX), an Australian provider of retirement income and investment management solutions, reported Monday higher net sales and Assets Under Management for the fi...
Challenger Earnings Call Transcript: H2 2026
Normalized EPS and NPAT rose 3% and 163% year-over-year, respectively, with strong annuity sales and robust capital strength under new APRA standards. Strategic initiatives include new retirement partnerships, product launches, and a major funds management merger, supporting medium-term EPS growth targets of 8%-10%.
Challenger Annual report: H2 2026
Challenger has published its H2 2026 annual report on August 17, 2026.
Challenger Earnings release: H2 2026
Challenger released its H2 2026 earnings on August 17, 2026, summarizing the period's financial results.
Challenger Slides: H2 2026
Challenger has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 17, 2026.
Challenger Press release: M&A announcement
Challenger issued a press release on June 17, 2026, disclosing material business information to investors.
Challenger Slides: M&A announcement
Challenger has posted slides in relation to its latest quarterly earnings report, which was published on June 17, 2026.
Challenger Transcript: Investor Day 2026
The business is leveraging demographic and regulatory tailwinds to scale retirement income solutions, driven by technology, partnerships, and capital reforms. Enhanced capital efficiency, digital transformation, and new offshore reinsurance capabilities position it for sustained growth and improved shareholder returns.
Challenger Slides: FY 2026
Challenger has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 25, 2026.
Challenger Earnings Call Transcript: H1 2026
H1 2026 saw earnings and returns above target, record annuity sales, and strong capital management, with an increased dividend and a planned AUD 150 million buyback. Strategic partnerships, technology upgrades, and offshore expansion position the business for continued growth.
Challenger Quarterly report: H1 2026
Challenger has published its H1 2026 quarterly earnings report on February 16, 2026.
Challenger Slides: H1 2026
Challenger has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 16, 2026.
Challenger Earnings release: H1 2026
Challenger released its H1 2026 earnings on February 16, 2026, summarizing the period's financial results.
Challenger Ltd. upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Julian Braganza upgraded Challenger Ltd. to Buy from Neutral with a A$6.89 price target. The company’s return on equity should continue to improve into fiscal 2024 primarily…
Challenger Ltd. upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst James Cordukes upgraded Challenger Ltd. to Outperform from Neutral with a price target of A$7.10, down from A$7.70. The analyst says value has emerged in the shares…
Challenger Ltd. downgraded to Sell from Neutral at Citi
Citi analyst Nigel Pittaway downgraded Challenger Ltd. to Sell from Neutral with a price target of A$7, up from A$6.90. Higher interest rates likely improve the outlook for Challenger’s retail…